[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2017-003295-31"
            },
            {
                "name": "Study Protocol Other Identifier",
                "value": "TALAPRO-2"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "mCRPC (metastatic castration-resistant prostate cancer)"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Pfizer Inc",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Inclusion Criteria:\r\n\r\n        Histologically or cytologically confirmed adenocarcinoma of the prostate withoutsmall cell\r\n        or signet cell features\r\n\r\n        Asymptomatic or mildly symptomatic metastatic castration resistant prostate cancer (mCRPC)\r\n        (score on BPI-SF Question #3 must be < 4).\r\n\r\n        For enrollment into Part 2 only (optional in Part 1): assessment of DDR mutation status\r\n\r\n        Consent to a saliva sample collection for a germline comparator unless prohibited by local\r\n        regulations or ethics committee decision (optional for patients in Part 1).\r\n\r\n        Surgically or medically castrated, with serum testosterone \u2264 50 ng/dL (\u2264 1.73 nmol/L) at\r\n        screening.\r\n\r\n        Metastatic disease in bone documented on bone scan or in soft tissue documented on CT/MRI\r\n        scan.\r\n\r\n        Progressive disease at study entry in the setting of medical or surgical castration as\r\n        defined by 1 or more of the following 3 criteria:\r\n\r\n          -  Prostate specific antigen (PSA) progression defined by a minimum of 2 rising PSA\r\n             values from 3 consecutive assessments with an interval of at least 7 days between\r\n             assessments..\r\n\r\n          -  Soft tissue disease progression as defined by RECIST 1.1.\r\n\r\n          -  Bone disease progression defined by Prostate Cancer Working Group 3 (PCWG3) with 2 or\r\n             more new metastatic bone lesions on a whole body radionuclide bone scan.\r\n\r\n        Ongoing bisphosphonate or denosumab use prior to Day 1 (Part 1) or randomization (Part 2)\r\n        is allowed but not mandatory.\r\n\r\n        Eastern Cooperative Oncology Group (ECOG) performance status \u2264 1.\r\n\r\n        Life expectancy \u2265 12 months as assessed by the investigator.\r\n\r\n        Able to swallow the study drug and have no known intolerance to study drugs or excipients.\r\n\r\n        Must agree to use a condom when having sex with a partner from the time of the first dose\r\n        of study drug through 4 months after last dose of study treatment. Must also agree for\r\n        female partner of childbearing potential to use an additional highly effective form of\r\n        contraception from the time of the first dose of study treatment through 4 months after\r\n        last dose of study treatment when having sex with a non pregnant female partner of\r\n        childbearing potential.\r\n\r\n        Must agree not to donate sperm from the first dose of study drug to 4 months after the last\r\n        dose of study drug.\r\n\r\n        Evidence of a personally signed and dated informed consent document (and molecular\r\n        prescreening consent if appropriate) indicating that the patient [or a legally acceptable\r\n        representative/legal guardian] has been informed of all pertinent aspects of the study.\r\n\r\n        Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and\r\n        other study procedures\r\n\r\n        Exclusion Criteria:\r\n\r\n        Any prior systemic cancer treatment initiated in in the non metastatic CRPC and mCRPC\r\n        disease state.\r\n\r\n        Patients whose only evidence of metastasis is adenopathy below the aortic bifurcation.\r\n\r\n        Prior treatment with second-generation androgen receptor inhibitors (enzalutamide,\r\n        apalutamide, and darolutamide), a PARP inhibitor, cyclophosphamide, or mitoxantrone for\r\n        prostate cancer.\r\n\r\n        Prior treatment with platinum-based chemotherapy within 6 months (from the last dose) prior\r\n        to Day 1 (Part 1) or randomization (Part 2), or any history of disease progression on\r\n        platinum-based therapy within 6 months (from the last dose).\r\n\r\n        Treatment with cytotoxic chemotherapy, biologic therapy including sipuleucel T, or\r\n        radionuclide therapy received in the castration-sensitive prostate cancer is NOT\r\n        exclusionary if discontinued in the 28 days prior to Day 1 (Part 1) or randomization (Part\r\n        2).\r\n\r\n        Treatment with any investigational agent within 4 weeks before Day 1 (Part 1) or\r\n        randomization (Part 2).\r\n\r\n        Prior treatment with opioids for pain related to either primary prostate cancer or\r\n        metastasis within 28 days prior to Day 1 (Part 1) or randomization (Part 2).\r\n\r\n        Current use of potent P-gp inhibitors within 7 days prior to Day 1 (Part 1) or\r\n        randomization (Part 2).\r\n\r\n        Major surgery (as defined by the investigator) within 2 weeks before Day 1 (Part 1) or\r\n        randomization (Part 2), or palliative localized radiation therapy within 3 weeks before\r\n        randomization (Part 2).\r\n\r\n        Clinically significant cardiovascular disease\r\n\r\n        Significant renal dysfunction as defined by any of the following laboratory abnormalities:\r\n\r\n        \u2022 Renal: eGFR < 30 mL/min/1.73 m2 by the MDRD equation (available via www.mdrd.com).\r\n\r\n        Patients enrolled in Part 1 only: Moderate renal impairment (eGFR 30-59 mL/min/1.73 m2) at\r\n        screening.\r\n\r\n        Significant hepatic dysfunction as defined by any of the following laboratory abnormalities\r\n        on screening labs:\r\n\r\n          -  Total serum bilirubin >1.5 times the upper limit of normal (ULN) (>3 \u00d7 ULN for\r\n             patients with documented Gilbert syndrome or for whom indirect bilirubin\r\n             concentrations suggest an extrahepatic source of elevation).\r\n\r\n          -  Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >2.5 times ULN (>5\r\n             \u00d7 ULN if liver function abnormalities are due to hepatic metastasis).\r\n\r\n          -  Albumin <2.8 g/dL\r\n\r\n        Absolute neutrophil count < 1500/\u00b5L, platelets < 100,000/\u00b5L, or hemoglobin < 9 g/dL (may\r\n        not have received growth factors or blood transfusions within 14 days before obtaining the\r\n        hematology values at screening).\r\n\r\n        Known or suspected brain metastasis or active leptomeningeal disease.\r\n\r\n        Symptomatic or impending spinal cord compression or cauda equina syndrome.\r\n\r\n        Any history of myelodysplastic syndrome, acute myeloid leukemia, or prior malignancy except\r\n        any of the following:\r\n\r\n          -  Carcinoma in situ or non melanoma skin cancer\r\n\r\n          -  Any prior malignancies \u22653 years before randomization with no subsequent evidence of\r\n             recurrence or progression regardless of the stage.\r\n\r\n          -  Stage 0 or Stage 1 cancer <3 years before randomization that has a remote probability\r\n             of recurrence or progression in the opinion of the investigator\r\n\r\n        Gastrointestinal disorder affecting absorption.\r\n\r\n        Fertile male subjects who are unwilling or unable to use highly effective methods of\r\n        contraception for the duration of the study and for 4 months after the last dose of\r\n        investigational product.\r\n\r\n        Investigator site staff members directly involved in the conduct of the study and their\r\n        family members, site staff members otherwise supervised by the investigator, or patients\r\n        who are Pfizer employees, including their family members, directly involved in the conduct\r\n        of the study.\r\n\r\n        Other acute or chronic medical (concurrent disease, infection, or comorbidity) or\r\n        psychiatric condition including recent (within the past year) or active suicidal ideation\r\n        or behavior or laboratory abnormality that interferes with ability to participate in the\r\n        study, may increase the risk associated with study participation or investigational product\r\n        administration, or may interfere with the interpretation of study results and, in the\r\n        judgment of the investigator, would make the patient inappropriate for entry into this\r\n        study.\r\n\r\n        History of seizure or any condition that may predispose to seizure (eg, prior cortical\r\n        stroke, significant brain trauma). Also, history of loss of consciousness or transient\r\n        ischemic attack within 12 months of randomization (Part 2)."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "Part 1 is an open-label, non-randomized, safety and PK run-in study designed to confirm the\r\n      starting dose of talazoparib in combination with enzalutamide through assessment of target\r\n      safety events and PK at select sites. Part 2 is a randomized, double-blind,\r\n      placebo-controlled, multinational study comparing talazoparib plus enzalutamide vs. placebo\r\n      plus enzalutamide in patients with mCRPC.",
        "official_title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER",
        "_phase_sort_order": 0,
        "collaborators": [
            {
                "name": "Astellas Pharma US Inc",
                "functional_role": "LABORATORY"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Day 1 up to 28 days",
                "name": "Confirm the dose of Talazoparib (part 1)",
                "description": "determined based on the safety profile",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "baseline up to 25 months",
                "name": "Duration of soft tissue response (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "duration of responses in patients with measurable soft tissue disease at baseline per RECIST 1.1",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Day 1 up to 26 months",
                "name": "Incidence of adverse events (part 1 and 2)",
                "description": "AEs and SAEs incidence by type and severity (graded by NCI CTCAE version 4.03)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 6 months",
                "name": "Objective response in measurable soft tissue disease (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "proportion of patients with measurable soft tissue disease at baseline with objective response per RECIST 1.1",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "Opiate use for cancer pain (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from randomization to opiate use for prostate cancer pain",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "Overall survival (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from randomization to death from any cause",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome: cancer specific global health status/QoL, functioning, and symptoms (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "change from baseline in patient-reported Global health status/QoL per EORTC QLQ-C30",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome: cancer specific global health status/QoL, functioning, and symptoms (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time to definitive deterioration in patient-reported global health status/QoL per EORTC QLQ-C30",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome: general health status (part 2) in unselected patients and patients harboring DDR deficiencies",
                "description": "time to definitive deterioration in patient-reported disease-specific urinary symptoms per EORTC QLQ-PR25",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome: general health status (part2) in unselected patients and patients harboring DDR deficiencies",
                "description": "change from baseline in patient-reported general health status per EQ-5D-5L",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome: pain symptoms (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time to deterioration in patient-reported pain symptoms per Brief Pain Inventory Short Form (BPI-SF)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 47 months",
                "name": "Patient-reported outcome:pain symptoms (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "change from baseline in patient-reported pain symptoms per Brief Pain Inventory Short Form (BPI-SF)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "PFS on next line of therapy (PFS2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "PFS2 based on investigator assessment",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "week 1, 5, 9, and 13",
                "name": "Pharmacokinetic assessment of enzalutamide (part 1)",
                "description": "plasma concentration of enzalutamide",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "week 3, 5, 9 13, and 17",
                "name": "Pharmacokinetic assessment of enzalutamide (part 2)",
                "description": "plasma concentration of enzalutamide",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Week 1, 5, 9, and 13",
                "name": "Pharmacokinetic assessment of talazoparib (part 1)",
                "description": "plasma concentration of talazoparib",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "week 3, 5, 9 13, and 17",
                "name": "Pharmacokinetic assessment of talazoparib (part 2)",
                "description": "plasma concentration of talazoparib",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 25 months",
                "name": "PSA response (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "proportion of patients with PSA response grater than or equal to 50%",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 25 months",
                "name": "Radiographic PFS (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from the date of randomization to first objective evidence of radiographic progression by blinded independent review, or death (occurring within 168 days of treatment discontinuation), whichever occurs first",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "Time to first symptomatic skeletal event (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from randomization to first symptomatic skeletal event (symptomatic fractures, spinal cord compression, surgery or radiation to the bone whichever is first)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "Time to initiation of antineoplastic therapy (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from randomization to initiation of antineoplastic treatment",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "randomization up to 47 months",
                "name": "Time to initiation of cytotoxic chemotherapy (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from randomization to initiation of cytotoxic chemotherapy",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "baseline up to 25 months",
                "name": "Time to PSA progression (part 2) in unselected patients and in patients harboring DDR deficiencies",
                "description": "time from baseline to PSA progression",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "III",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03395197",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Elevated PSA",
                    "Elevated Prostate Specific Antigen",
                    "Increasing PSA",
                    "PSA Elevated",
                    "Prostate Specific Antigen Progression",
                    "Rising PSA"
                ],
                "nci_thesaurus_concept_id": "C123611",
                "name": "PSA Progression",
                "semantic_types": [
                    "Finding",
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C138961",
                    "C3367",
                    "C77140",
                    "C21281",
                    "C16612",
                    "C26003",
                    "C25804",
                    "C26585",
                    "C36292"
                ],
                "parents": [
                    "C138961",
                    "C26585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Protease Gene",
                    "Proteinase Gene"
                ],
                "nci_thesaurus_concept_id": "C26003",
                "name": "Peptidase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25804",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25804"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157377",
                "name": "Testosterone Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C138961",
                "name": "PSA Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C36292",
                    "C16612",
                    "C26585",
                    "C77140",
                    "C3367",
                    "C25804",
                    "C26003"
                ],
                "parents": [
                    "C26585",
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C129259",
                "name": "Castration Levels of Testosterone",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140",
                    "C157377"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "KLK3",
                    "Kallikrein 3, (Prostate Specific Antigen) Gene",
                    "PSA"
                ],
                "nci_thesaurus_concept_id": "C26585",
                "name": "KLK3 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C25804",
                    "C16612",
                    "C21281",
                    "C26003"
                ],
                "parents": [
                    "C26003"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Hydrolase Family Gene"
                ],
                "nci_thesaurus_concept_id": "C25804",
                "name": "Hydrolase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2022-01-20",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "CRPC",
                    "Castration-Resistant Prostate Carcinoma",
                    "Metastatic Castration-Resistant Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C130234",
                "name": "Castration-Resistant Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C167255",
                    "C8946"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma Metastatic in the Soft Tissue",
                    "Metastatic Prostate Carcinoma in the Soft Tissue"
                ],
                "nci_thesaurus_concept_id": "C132881",
                "name": "Metastatic Prostate Cancer in the Soft Tissue",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8946",
                    "C114831"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Prostate Carcinoma AJCC v8",
                    "Stage IV Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140173",
                "name": "Stage IV Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140163"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Prostate Carcinoma AJCC v8",
                    "Stage IVA Prostate Cancer AJCC v8",
                    "IVA"
                ],
                "nci_thesaurus_concept_id": "C140174",
                "name": "Stage IVA Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Prostate Carcinoma AJCC v8",
                    "Stage IVB Prostate Cancer AJCC v8",
                    "IVB"
                ],
                "nci_thesaurus_concept_id": "C140175",
                "name": "Stage IVB Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "PRAD",
                    "Adenocarcinoma of Prostate",
                    "Adenocarcinoma of the Prostate"
                ],
                "nci_thesaurus_concept_id": "C2919",
                "name": "Prostate Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C48596"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma Metastatic to the Bone"
                ],
                "nci_thesaurus_concept_id": "C36308",
                "name": "Prostate Carcinoma Metastatic in the Bone",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8946",
                    "C36082"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Cancer Metastatic",
                    "Prostate Carcinoma Metastatic",
                    "Metastatic Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C8946",
                "name": "Metastatic Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167255",
                "name": "Refractory Prostate Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C177149"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Urogenital Carcinoma",
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C3482",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150534",
                "name": "Refractory Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Male reproductive system cancer, NOS",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Male Reproductive System",
                    "Male Reproductive System Tumor",
                    "Tumor of Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm",
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of Reproductive System",
                    "Tumor of the Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3343",
                    "C8561"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Male Reproductive System Disease",
                    "Disorder of Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer",
                    "Malignant Genitourinary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C8561"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Genitourinary System Malignant Neoplasm",
                    "Metastatic Malignant Genitourinary System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Cancer",
                    "resistant cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Cancer of the Prostate",
                    "Other Prostate Carcinoma",
                    "Carcinoma of Prostate",
                    "Carcinoma of the Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177149",
                "name": "Refractory Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C181196",
                    "C150534",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Urogenital Disease",
                    "Genitourinary Disorder"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Connective Tissue",
                    "Primary Disorder of Connective Tissue",
                    "Connective Tissue Disease",
                    "Connective Tissue Diseases",
                    "Connective Tissue Disorders"
                ],
                "nci_thesaurus_concept_id": "C26729",
                "name": "Connective Tissue Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27574"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Musculoskeletal System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C166354",
                "name": "Musculoskeletal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C107377",
                    "C3810"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Connective and Soft Tissue Diseases",
                    "Connective and Soft Tissue Disease"
                ],
                "nci_thesaurus_concept_id": "C27574",
                "name": "Connective and Soft Tissue Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C166357",
                "name": "Malignant Musculoskeletal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C166354"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C9480",
                "name": "Invasive Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8505",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Infiltrating Prostate Carcinoma",
                    "Invasive Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C48596",
                "name": "Invasive Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C9480"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Malignant Neoplasm in the Soft Tissues",
                    "Metastatic Malignant Neoplasm to the Soft Tissues"
                ],
                "nci_thesaurus_concept_id": "C114831",
                "name": "Metastatic Malignant Neoplasm to Soft Tissues",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of the Bone",
                    "Bone cancer, NOS",
                    "Malignant Osseous Tumor",
                    "Malignant Neoplasm of Bone",
                    "Malignant Bone Tumor",
                    "Malignant Tumor of Bone",
                    "Osseous Cancer",
                    "Cancer of the Bone",
                    "Cancer of Bone",
                    "Malignant Neoplasm of the Bone",
                    "Malignant Bone Neoplasm",
                    "Malignant Osseous Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4016",
                "name": "Bone Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9343",
                    "C166357"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "invasive cancer",
                    "infiltrating cancer",
                    "Infiltrating Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8505",
                "name": "Invasive Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Musculoskeletal System",
                    "Musculoskeletal System Disorder"
                ],
                "nci_thesaurus_concept_id": "C107377",
                "name": "Musculoskeletal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27574"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Neoplasm to the Bone",
                    "Metastases to bone, NOS",
                    "Metastatic Malignant Neoplasm in the Bone",
                    "Bone Metastasis",
                    "Metastatic Tumor to the Bone",
                    "Bone Metastases",
                    "Metastatic Cancer to the Bone"
                ],
                "nci_thesaurus_concept_id": "C3580",
                "name": "Metastatic Malignant Neoplasm to the Bone",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4016",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathologic)",
                    "Prostate Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140163",
                "name": "Prostate Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4863"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Carcinoma to the Bone"
                ],
                "nci_thesaurus_concept_id": "C36082",
                "name": "Metastatic Carcinoma in the Bone",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C3580"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Osseous Neoplasm",
                    "Neoplasm of the Bone",
                    "Osseous Tumor",
                    "Bone Neoplasms",
                    "Tumor of Bone",
                    "Bone Tumor",
                    "Bone Tumors",
                    "Neoplasm of Bone",
                    "Tumor of the Bone"
                ],
                "nci_thesaurus_concept_id": "C9343",
                "name": "Bone Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C166354",
                    "C26729"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Soft Tissue and Bone Tumor",
                    "Tumor of Skeletal and Soft Tissue",
                    "Tumor of Soft Tissue and Bone",
                    "Musculoskeletal and Soft Tissue Neoplasm",
                    "Neoplasm of Skeletal and Soft Tissue",
                    "Skeletal and Soft Tissue Tumor",
                    "Neoplasm of Soft Tissue and Skeleton",
                    "Skeletal and Soft Tissue Neoplasm",
                    "Tumor of Soft Tissue and Skeleton",
                    "Connective and Soft Tissue Tumor",
                    "Soft Tissue and Bone Neoplasm",
                    "Neoplasm of Soft Tissue and Bone",
                    "Musculoskeletal and Soft Tissue Tumor"
                ],
                "nci_thesaurus_concept_id": "C3810",
                "name": "Connective and Soft Tissue Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27574",
                    "C3263"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "C3441021",
        "active_sites_count": 4,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "AR Antagonist",
                            "Androgen Receptor Antagonist",
                            "AR Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C146993",
                        "name": "Androgen Receptor Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Procedure",
                            "Intervention"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Agent",
                            "Pharmacologic Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Method",
                            "Therapy",
                            "Therapeutic Technique",
                            "Therapeutic Interventions",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C95733",
                        "name": "Talazoparib",
                        "description": "An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. PARP inhibitor BMN-673 selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C62554"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Xtandi"
                        ],
                        "nci_thesaurus_concept_id": "C71744",
                        "name": "Enzalutamide",
                        "description": "An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Androgen",
                            "Androgen Antagonists",
                            "Anti-Androgen Agents",
                            "Antiandrogen Agents",
                            "Antiandrogens"
                        ],
                        "nci_thesaurus_concept_id": "C242",
                        "name": "Antiandrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Poly (ADP-Ribose) Polymerase Inhibitor",
                            "Poly(ADP-Ribose) Polymerase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C62554",
                        "name": "PARP Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Antagonist",
                            "Antihormone Agents"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Therapy Agent",
                            "Hormonal Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Anti-tumor Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C116558",
                        "name": "Placebo Administration",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastic Drugs",
                            "Anti-Tumor Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Combination arm",
                "description": "Talazoparib plus enzalutamide",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Monotherapy arm",
                "description": "Ezalutamide plus placebo",
                "type": "ACTIVE_COMPARATOR"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-01651",
        "why_study_stopped": null,
        "brief_summary": "This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs.\r\n      enzalutamide after confirmation of the starting dose of talazoparib in combination with\r\n      enzalutamide.",
        "brief_title": "Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC",
        "status_history": [
            {
                "status_date": "2022-01-20T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2017-12-18T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 1150,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2017-12-18",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": "TALAPRO-2",
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-07-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]